Mekiri Bio
Boston, US · Founded 2025 · Delaware corporation
Founders & leadership
DL
Debbie LinExecutive
AD
Anita DiFazioExecutive
Board
AD
Aaron DiAntonioBoard director
CM
Corey McCannBoard director
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2025
▶$1MraisedOct 2025 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedOct 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Debbie LinExecutive Officer
- Anita DiFazioExecutive Officer
- Aaron DiAntonioDirector
- Corey McCannDirector
- Offering amount
- $2M
- Amount sold
- $1M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Mekiri Bio raised?
- Mekiri Bio has disclosed $1M raised across 1 round.
- Where is Mekiri Bio headquartered?
- Mekiri Bio is headquartered in Boston, US.